Notes
incremental cost-effectiveness ratio
Reference
Pink J, et al. Cost-effectiveness of pharmacogenetic guided warfarin therapy versus alternative anticoagulation in atrial fibrillation. Clinical Pharmacology and Therapeutics : 25 Sep 2013. Available from: URL: http://dx.doi.org/10.1038/clpt.2013.190
Rights and permissions
About this article
Cite this article
Best choice for stroke prevention in AF?. PharmacoEcon Outcomes News 689, 7 (2013). https://doi.org/10.1007/s40274-013-0793-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0793-8